BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 8585564)

  • 1. Benzoate therapy and carnitine deficiency in non-ketotic hyperglycinemia.
    Van Hove JL; Kishnani P; Muenzer J; Wenstrup RJ; Summar ML; Brummond MR; Lachiewicz AM; Millington DS; Kahler SG
    Am J Med Genet; 1995 Dec; 59(4):444-53. PubMed ID: 8585564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical progress of neonatal non-ketotic hyperglycinemia under treatment].
    García-Pérez A; Martínez-Granero MA; Martín-Ancel AM; Bonet-Serra B; García-Muñoz MJ; García-Segura JM; Viaño J; Lama-More RA
    Rev Neurol; 2004 Oct 16-31; 39(8):727-30. PubMed ID: 15514900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of early dextromethorphan and sodium benzoate therapy in an infant with nonketotic hyperglycinemia.
    Zammarchi E; Donati MA; Ciani F; Pasquini E; Pela I; Fiorini P
    Neuropediatrics; 1994 Oct; 25(5):274-6. PubMed ID: 7885541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of urinary carnitine profile induced by benzoate administration.
    Sakuma T
    Arch Dis Child; 1991 Jul; 66(7):873-5. PubMed ID: 1863104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonketotic hyperglycinemia in a newborn infant.
    Tekinalp G; Coşkun T; Oran O; Ozalp I; Figen G; Ergin H
    Turk J Pediatr; 1995; 37(1):57-60. PubMed ID: 7732609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of strychnine treatment during the neonatal period in three Finnish children with nonketotic hyperglycinemia.
    von Wendt L; Similä S; Saukkonen AL; Koivisto M
    Pediatrics; 1980 Jun; 65(6):1166-9. PubMed ID: 7375243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypocarnitinemia in patients affected by a primary defect of ammonia metabolism treated with sodium benzoate].
    Michalak A; Lambert MA; Dallaire L; Melançon SB; Laframboise R; Lemieux B; Qureshi IA
    Diabete Metab; 1990; 16(3):226-33. PubMed ID: 2210018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-ketotic hyperglycinemia: clinical and therapeutic course in three patients].
    Rite Gracia S; Guallarte Alias MP; Martínez Moral M; Baldellou Vázquez A; Rite Montañés S; Ruiz-Echarri Zalaya MP; Marco Tello A; Rebage Moisés V
    An Esp Pediatr; 1999 Apr; 50(4):408-10. PubMed ID: 10356838
    [No Abstract]   [Full Text] [Related]  

  • 9. [Carnitine in the treatment of methylmalonic aciduria (MMA)].
    Penn D; Schmidt H; Otten A; Schmidt-Sommerfeld E
    Monatsschr Kinderheilkd; 1986 Oct; 134(10):758-61. PubMed ID: 2879226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hyperglycinemia without ketosis. Biochemical and enzymatic study].
    Dingeon N; Rolland MO; Divry P; Cotte J
    Ann Biol Clin (Paris); 1977; 35(1):33-7. PubMed ID: 907224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Carnitine deficiency in inborn errors of metabolism].
    Sela BA; Lerman-Sagie T; Berkovitz M
    Harefuah; 1997 Nov; 133(10):419-23, 504. PubMed ID: 9418309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of benzoate in the management of seizures in nonketotic hyperglycinemia.
    Wolff JA; Kulovich S; Yu AL; Qiao CN; Nyhan WL
    Am J Dis Child; 1986 Jun; 140(6):596-602. PubMed ID: 3706242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early treatment of severe infantile glycine encephalopathy (nonketotic hyperglycinemia) with strychnine and sodium benzoate.
    Melançon SB; Dallaire L; Vincelette P; Potier M; Geoffroy G
    Prog Clin Biol Res; 1979; 34():217-29. PubMed ID: 531053
    [No Abstract]   [Full Text] [Related]  

  • 14. [Strychnine in non-ketotic hyperglycinemia].
    Arenz B; Rister M; Sanchez A
    Monatsschr Kinderheilkd; 1982 Aug; 130(8):621-3. PubMed ID: 7133018
    [No Abstract]   [Full Text] [Related]  

  • 15. [Profile of hepatic and muscular acylcarnitines in chronically hyperammonemic mice after an acute treatment with sodium benzoate: dose-response study].
    Michalak A; Qureshi IA
    Ann Biol Clin (Paris); 1993; 51(10-11):879-85. PubMed ID: 8210064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia.
    Hamosh A; Maher JF; Bellus GA; Rasmussen SA; Johnston MV
    J Pediatr; 1998 Apr; 132(4):709-13. PubMed ID: 9580775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical finding and therapeutic problems in non-ketotic hyperglycinemia.
    Koepp P; de Groot CJ; Grüttner R; Rybak C
    Helv Paediatr Acta; 1973 Nov; 28(5):459-65. PubMed ID: 4773226
    [No Abstract]   [Full Text] [Related]  

  • 18. [Carnitine levels in muscle in mice with hyperammonemia: effect of treatment with sodium benzoate].
    Michalak A; Qureshi IA
    Can J Physiol Pharmacol; 1993 Jul; 71(7):439-46. PubMed ID: 8242478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excretion of hippuric acid during sodium benzoate therapy in patients with hyperglycinaemia or hyperammonaemia.
    Barshop BA; Breuer J; Holm J; Leslie J; Nyhan WL
    J Inherit Metab Dis; 1989; 12(1):72-9. PubMed ID: 2501586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Citrullinemia. Clinical experience with 23 cases.
    Tokatli A; Coşkun T; Ozalp I
    Turk J Pediatr; 1998; 40(2):185-93. PubMed ID: 9677723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.